Abstracts for the British Association of Dermatologists 102nd Annual Meeting

ABSTRACT

The proceedings contain 388 papers. The topics discussed include vitiligo diagnosis is associated with an increase in new-onset depression and anxiety a population-based cohort study in the UK;effect modification of biologic survival by patient characteristics a prospective cohort study from the British Association of Dermatologists Biologics And Immunomodulators Register;'a raised P3NP is a matter of time' replacing P3NP with FIB-4 for monitoring of methotrexate-related liver fibrosis;a randomized controlled trial assessing the effectiveness and safety of ciclosporin vs. methotrexate in the treatment of severe atopic eczema in children and young people the treatment of severe atopic eczema trial (TREAT);carbonylated proteins as markers of oxidative stress and their association with filaggrin genotype in atopic eczema;skin tumors in England 2013-2019 in-depth reporting of a new consensus classification to improve prospective data extraction and clinical interpretation;a national review of porocarcinoma epidemiology in England 2013-2018;national Merkel cell carcinoma epidemiology and mortality-related risk factors in England 2004-2018;and hospitalization from COVID-19 is most frequently observed in patients with atopic dermatitis treated with systemic corticosteroids, and in particular when systemic corticosteroids are used in combination with another immunomodulatory treatment lessons from the global SECURE-AD registry.